Search
for
Sort by
Research 181–210 of 1000+
- A Retrospective Analysis from Turkey: The Effect of the COVID-19 Outbreak Quarantine on Dermatology Outpatient Clinics
- Wound Healing: A Cellular Perspective
- Efficacy of Off-Label Topical Treatments for the Management of Androgenetic Alopecia: A Review
- ALOPESİ AREATA OLGULARINDA SANAT TERAPİSİNİN KULLANILMASI: BİR OLGU SUNUMU
- Bimatoprost in the treatment of eyelash hypotrichosis
- JAK Inhibitors for Treatment of Alopecia Areata
- Evaluating the Therapeutic Potential of Ritlecitinib for the Treatment of Alopecia Areata
- Demodicosis in Different Age Groups and Alternative Treatment Options—A Review
- Baricitinib for the Treatment of Alopecia Areata
- II Consensus of the Brazilian Society of Dermatology for the treatment of alopecia areata
- Biological therapy in the treatment of melanoma
- Advance and Challenges in the Treatment of Skin Diseases with the Transdermal Drug Delivery System
- Mind–Body Integrative Treatment of Psychodermatoses
- 75993 Safety of Janus kinase inhibitors for treatment of alopecia areata
- Consensus position statement on emerging treatments in dermatology by the Association of Cutaneous Surgeons of India Task Force
- Considerations for the Treatment Strategy of Relapse After Tofacitinib Therapy in Alopecia Areata
- Anatomical view of administration route of Murdha Taila
- Efficacy of derinat as a treatment for murine and androgenetic alopecia (AGA) patients
- A Comprehensive Literature Review of JAK Inhibitors in Treatment of Alopecia Areata
- Polymeric nanoparticles‐based topical delivery systems for the treatment of dermatological diseases
- Role of janus kinase inhibitors in the treatment of alopecia areata
- 9-cis-Retinoic Acid Capsules in the Treatment of AIDS-Related Kaposi Sarcoma
- Therapeutic potential of bimatoprost for the treatment of eyebrow hypotrichosis
- Cronkhite–Canada syndrome: from clinical features to treatment
- Successful hair regrowth in a Korean patient with alopecia universalis following tofacitinib treatment
- Safety of Baricitinib in Adults with Severe Alopecia Areata from Two Phase III Trials Over a Median of 2.3 Years and Up to 4 Years of Treatment
- Cannabinoid Compounds as a Pharmacotherapeutic Option for the Treatment of Non-Cancer Skin Diseases
- Novel Janus Kinase Inhibitors in the Treatment of Dermatologic Conditions
- Use of oral Janus kinase inhibitors for the treatment of severe alopecia areata: narrative review and real-world experience
- Cutaneous Adverse Effects of EGFR Therapy in Breast Cancer Treatment